Author

Kentaro Tanaka

Kagoshima UniversityORCID 0000-0003-4602-4465Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Kentaro Tanaka1 paper · Research Institute for Microbial Diseases, The University of Osaka

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Daisuke ShibaharaiD· 2 shared Eiji IwamaiD· 2 shared Isamu OkamotoiD· 2 shared Kohei OtsuboiD· 2 shared Aiko Hirayama· 1 shared Atsushi Shimauchi· 1 shared Hiroe Shuto· 1 shared Kazuya TsubouchiiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Daisuke ShibaharaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintOct 27, 2026

Inflammatory signaling drives SQSTM1-dependent suppression of interferon-γ-induced MHC class I

Sho Yamashita, Hiroe Shuto, Aiko Hirayama…·Kentaro Tanaka

This study shows that IL-1β suppresses IFN-γ-induced MHC-I surface expression in NSCLC cells through SQSTM1-dependent autophagy, revealing a post-transcriptional regulatory mechanism.

DOI 10.64898/2026.10.23.761340

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintFeb 10, 2025

Spatial dynamics of the tumor microenvironment associated with emerging resistance to targeted therapy in EGFR-mutated non-small cell lung cancer

Satoshi Nakamura, Daisuke Shibahara, Kentaro Tanaka…·Isamu Okamoto

The paper uses spatial transcriptomics to analyze pre- and post-treatment tumor samples, identifying fibroblast activation and tumor heterogeneity as factors in early EGFR-TKI resistance.

1 citation

humanspatial transcriptomics

𝕏 PostBluesky